Organon & Co | OGN - Pendapatan Penjualan





Penjualan Perubahan Tanggal
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Celltrion KRW 1.33T 0 2026-03
Cspc Pharmaceutical CNY 6.11B 502.75M 2025-12
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Merck USD 16.29B 110M 2026-03
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Novartis USD 13.11B 750M 2026-03
Organigram Holdings CAD 63.54M 16.52M 2025-12
Organon & Co USD 1.51B 90M 2025-12
Pharma Mar EUR 90.2M 54.5M 2025-12
Qiagen NV USD 419.22M 38.16M 2026-03
Sartorius EUR 899.1M 28.5M 2026-03
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Tilray USD 217.51M 74.75M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12